Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy
The objective of this study was to perform a Budget Impact Analysis (BIA) assessing the introduction of Tripliam for the treatment of hypertension into the Italian market. Tripliam is the first and only available single-tablet triple combination antihypertensive therapy containing perindopril, amlodipine and indapamide, in line with current evidence-based recommendations for the treatment and management of hypertension.
Source: Value in Health - Category: Global & Universal Authors: EP Lanati, VL Orlando Source Type: research
More News: Budgets | Health | Hypertension | Indapamide | International Medicine & Public Health | Norvasc | Study